Schrodinger, Inc.
SDGR
34 insider filings · Latest: Sep 17, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Sep 21 9:15 PM | Karen AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Sale | 31,599 | $29.37 | $928.0K | 69,956(D) | View → |
| Sep 17, 2026 | Sep 17 8:27 PM | KAREN OLUFUNMILYO AKINSANYA-AKIWUMI | Proposed Sale | 31,599 | $23.93 | $756.2K | — | View → |
| Jul 16, 2026 | Jul 17 9:09 PM | Rachit JainEVP & CFO | Sale | 875 | $15.60 | $13.6K | 50,877(D) | View → |
| Jul 16, 2026 | Jul 16 7:19 PM | Jain Rachit | Proposed Sale | 875 | $15.60 | $13.6K | — | View → |
| Jul 1, 2026 | Jul 1 7:19 PM | Aklian Mannix Vartan | Proposed Sale | 1,136 | $16.68 | $18.9K | — | View → |
| May 1, 2026 | May 1 7:18 PM | Herman Jenny | Proposed Sale | 1,957 | $12.26 | $24.0K | — | View → |
| Apr 17, 2026 | Apr 17 10:09 PM | Ramy FaridDirector, President & CEO | Sale | 43,000 | $12.21 | $524.9K | 330,824(D) | View → |
| Apr 16, 2026 | Apr 17 10:09 PM | Ramy FaridDirector, President & CEO | Sale | 43,000 | $12.33 | $530.2K | 330,824(D) | View → |
| Apr 16, 2026 | Apr 17 10:07 PM | Rachit JainEVP & CFO | Sale | 844 | $12.75 | $10.8K | 51,752(D) | View → |
| Apr 16, 2026 | Apr 16 8:14 PM | RAMY SAMIR FARID | Proposed Sale | 86,000 | $12.40 | $1.1M | — | View → |
| Apr 16, 2026 | Apr 16 7:10 PM | Jain Rachit | Proposed Sale | 844 | $12.75 | $10.8K | — | View → |
| Mar 6, 2026 | Mar 6 10:29 PM | Jenny HermanCAO | Sale | 608 | $12.84 | $7.8K | 34,804(D) | View → |
| Mar 5, 2026 | Mar 6 10:29 PM | Jenny HermanCAO | Sale | 775 | $12.85 | $10.0K | 35,412(D) | View → |
| Mar 5, 2026 | Mar 6 10:29 PM | Rachit JainEVP & CFO | Sale | 1,631 | $12.90 | $21.0K | 52,596(D) | View → |
| Mar 5, 2026 | Mar 6 10:28 PM | Yvonne TranEVP, CLO & CPO | Sale | 1,094 | $12.90 | $14.1K | 52,683(D) | View → |
| Mar 5, 2026 | Mar 6 10:28 PM | Ramy FaridDirector, President & CEO | Sale | 3,661 | $12.91 | $47.2K | 330,824(D) | View → |
| Mar 5, 2026 | Mar 6 10:27 PM | Karen AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships | Sale | 1,366 | $12.90 | $17.6K | 69,956(D) | View → |
| Mar 5, 2026 | Mar 6 10:26 PM | Kenneth Patrick LortonEVP, CTO & COO, Software | Sale | 1,222 | $12.90 | $15.8K | 89,241(D) | View → |
| Mar 4, 2026 | Mar 6 10:26 PM | Robert Lorne AbelEVP, Chief Scientific Officer, Platform | Sale | 1,300 | $12.81 | $16.7K | 55,897(D) | View → |
| Mar 6, 2026 | Mar 6 8:18 PM | Herman Jenny | Proposed Sale | 608 | $12.84 | $7.8K | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 3 9:30 PM | Robert Lorne AbelEVP, Chief Scientific Officer, Platform | Grant/Award | 34,250 | $12.15 | 34,250(D) | View → |
← Previous
Page 2 of 2